Evidence map›Paper›PMID 39747579›Full record

ArticleNature cell biology2025

AMPK-regulated glycerol excretion maintains metabolic crosstalk between reductive and energetic stress.

Xuewei Zhai, Ronghui Yang, Qiaoyun Chu, Zihao Guo, Pengjiao Hou, Xuexue Li, Changsen Bai, Ziwen Lu, Luxin Qiao, Yanxia Fu and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Chemical Bond-Orchestrated Energy Depletion to Augment Lung Cancer Chemo-Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Reductive stress in cancer immunology and targeted therapy.Acta biochimica et biophysica Sinica · 2026
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Genome-wide analysis of theFrontiers in plant science · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xuewei Zhai *Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-5645-4373
Ronghui Yang *Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-9765-9666
Qiaoyun ChuDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Zihao GuoBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Pengjiao HouBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Xuexue LiBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Changsen BaiDepartment of Cancer Cell Biology and National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Ziwen LuBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0002-0744-1533
Luxin QiaoBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Yanxia FuDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Jing NiuDepartment of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Binghui LiBeijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing, China. bli@ccmu.edu.cn.ORCID http://orcid.org/0000-0002-6110-8010

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82030093National Natural Science Foundation of China (National Science Foundation of China) 82325038
6 · The paper itself

Abstract

Glucose metabolism has been studied extensively, but the role of glucose-derived excretory glycerol remains unclear. Here we show that hypoxia induces NADH accumulation to promote glycerol excretion and this pathway consumes NADH continuously, thus attenuating its accumulation and reductive stress. Aldolase B accounts for glycerol biosynthesis by forming a complex with glycerol 3-phosphate dehydrogenases GPD1 and GPD1L. Blocking GPD1, GPD1L or glycerol 3-phosphate phosphatase exacerbates reductive stress and suppresses cell proliferation under hypoxia and tumour growth in vivo. Overexpression of these enzymes increases glycerol excretion but still reduces cell viability under hypoxia and tumour proliferation due to energy stress. AMPK inactivates aldolase B to mitigate glycerol synthesis that dissipates ATP, alleviating NADH accumulation-induced energy crisis. Therefore, glycerol biosynthesis/excretion regulates the trade-off between reductive stress and energy stress. Moreover, this mode of regulation seems to be prevalent in reductive stress-driven transformations, enhancing our understanding of the metabolic complexity and guiding tumour treatment.

Indexed as

AMP-Activated Protein KinasesEnergy MetabolismGlycerolStress, PhysiologicalAnimalsCell HypoxiaCell Line, TumorCell ProliferationFructose-Bisphosphate AldolaseGlucoseGlycerol-3-Phosphate Dehydrogenase (NAD+)Glycerolphosphate DehydrogenaseHumansMiceMice, NudeNADAMP-Activated Protein KinasesFructose-Bisphosphate AldolaseGlucoseGlycerolGlycerol-3-Phosphate Dehydrogenase (NAD+)Glycerolphosphate DehydrogenaseNAD

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.